Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carvedilol versus placebo for primary prophylaxis of oesophageal varices in cirrhosis
ISRCTN10324656Phase 4Active, not recruiting
- Sponsor
- King's College Hospital
- Start
- Apr 2019
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial of carvedilol in Cirrhosis and esophageal varices, sponsored by King's College Hospital. Primary endpoint: All-cause decompensation. Started Apr 2019; status: active, not recruiting.
02
Drugs
carvedilol
03
Conditions
Cirrhosisesophageal varices
Beyond the preview
Go deeper on ISRCTN10324656.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN10324656.